Savara Pharmaceuticals
SVRA
#6613
Rank
NZ$0.87 B
Marketcap
$5.08
Share price
-6.58%
Change (1 day)
-16.33%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$93.24 Million a decrease over its 2022 earnings that were of -NZ$65.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion32.74%
2023 -NZ$93.24 Million43.38%
2022 -NZ$65.03 Million-11.31%
2021 -NZ$73.32 Million-13.3%
2020 -NZ$84.57 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$56.99 Million34.11%
2016 -NZ$42.5 Million-37.43%
2015 -NZ$67.92 Million38.81%
2014 -NZ$48.93 Million33.62%
2013 -NZ$36.62 Million38.49%
2012 -NZ$26.44 Million24.59%
2011 -NZ$21.23 Million-36.5%
2010 -NZ$33.42 Million-3.14%
2009 -NZ$34.51 Million-23.28%
2008 -NZ$44.97 Million8.52%
2007 -NZ$41.44 Million-34.14%
2006 -NZ$62.93 Million184.43%
2005 -NZ$22.13 Million90.75%
2004 -NZ$11.6 Million190.35%
2003 -NZ$4 Million11.64%
2002 -NZ$3.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$30.95 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.42 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA